Revenue increased 5.2%
Revenue changed +5.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue changed +5.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Inventory / revenue changed -218 basis points from the comparable as-filed period.
Operating income changed +4.3% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating margin changed -4 basis points from the comparable as-filed period.
Net income changed -7.5% from the comparable as-filed period.
SBC / revenue changed -0 basis points from the comparable as-filed period.
Stock-based compensation changed +4.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory changed +0.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.